Showing results (231-240 of 314) with videos related to
Sort By:
Pageof 32
Molecular Cell|February 1, 2020
Toward a Structural Understanding of Class B GPCR Peptide Binding and ActivationYi-Lynn Liang, Matthew J Belousoff, Peishen Zhao, et al.Endocrinology|December 6, 2003
Tyrosine agonists reverse the molecular defects associated with dominant-negative mutations in human peroxisome proliferator-activated receptor gammaMaura Agostini, Mark Gurnell, David B Savage, et al.Science (New York, N.Y.)|March 23, 2013
Structural features for functional selectivity at serotonin receptorsDaniel Wacker, Chong Wang, Vsevolod Katritch, et al.Science Signaling|July 7, 2011
Identification of a lysosomal pathway that modulates glucocorticoid signaling and the inflammatory responseYuanzheng He, Yong Xu, Chenghai Zhang, et al.The EMBO Journal|November 27, 2014
A dysregulated acetyl/SUMO switch of FXR promotes hepatic inflammation in obesityDong-Hyun Kim, Zhen Xiao, Sanghoon Kwon, et al.Nature Communications|November 1, 2017
Combining chemical and genetic approaches to increase drought resistance in plantsMin-Jie Cao, Yu-Lu Zhang, Xue Liu, et al.Cell Research|May 23, 2023
Structural genomics of the human dopamine receptor systemPeiyu Xu, Sijie Huang, Brian E Krumm, et al.Journal of Medicinal Chemistry|May 8, 2026
Discovery and Characterization of Benzamide Derivatives as Highly Potent SUCNR1 Antagonists for Cancer ImmunotherapyZhiyuan Cheng, Jiacheng He, Changyao Li, et al.Proceedings of the National Academy of Sciences of the United States of America|March 4, 2011
Benzoquinone ansamycin 17AAG binds to mitochondrial voltage-dependent anion channel and inhibits cell invasionQian Xie, Robert Wondergem, Yuehai Shen, et al.Journal of Medicinal Chemistry|February 11, 2021
Kinetics-Driven Drug Design Strategy for Next-Generation Acetylcholinesterase Inhibitors to Clinical CandidateYu Zhou, Yan Fu, Wanchao Yin, et al.Pageof 32